Skip to main content

Advertisement

SpringerLink
Log in

Plasma Fibrinogen Level: an Independent Risk Factor for Long-term Survival in Chinese Patients with Peripheral Artery Disease?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Fibrinogen, an inflammatory marker as well as a fundamental part of the coagulation cascade, is suggested to play a significant role in the pathogenesis of atherosclerosis and complications of atherothrombotic diseases. The aim of this study was to determine if plasma fibrinogen is an independent risk factor for long-term survival in patients with peripheral artery disease (PAD). Altogether, 139 Chinese patients (88 men, 51 women) with PAD were consecutively recruited for the study. Atherothrombotic risk factors and fibrinogen levels were determined at presentation, and all patients were followed up for mortality prospectively. The mean follow-up was 6 years. All variables were first correlated with survival rates using Kaplan-Meier analysis and compared by means of the log-rank test. Significant risk factors were identified, and multivariate Cox regression analysis was used to evaluate the independent contribution of the fibrinogen level to the risk of mortality. During follow-up, 95 patients (68.3%) died. The overall survival rate was 77.7% at 3 years, 56.8% at 5 years, and 31.2% at 10 years (standard errors 0.05, 0.06, and 0.07, respectively). All-cause mortality rate increased with an elevated fibrinogen level. Eighty percent of patients with a fibrinogen level > 3.4 g/L had a survival time of less than 3 years (p = 0.002). This relation was also demonstrated within patients with critical ischemia. The plasma fibrinogen level was thus identified as an independent risk factor for mortality in PAD patients after adjusting for confounding factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Smith FB, Lee AJ, Hau CM, et al. Plasma fibrinogen, hemostatic factor and prediction on peripheral artery disease in the Edinburgh Artery Study. Blood Coagul. Fibrinolysis 2000;11:43–50

    CAS  PubMed  Google Scholar 

  2. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta 3 integrin, and GPIbalpha. J. Exp. Med. 1998;187:329–339

    Article  CAS  PubMed  Google Scholar 

  3. Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990;10:1–7

    CAS  PubMed  Google Scholar 

  4. Mannucci PM, Recent progress in the pathophysiology of fibrinogen. Eur. Heart J. 1995;16:25–30

    CAS  PubMed  Google Scholar 

  5. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001;104:503–516

    Article  CAS  PubMed  Google Scholar 

  6. Lusis AJ Atheroslceorsis. Nature 2000;407:233–241

    Article  CAS  PubMed  Google Scholar 

  7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–1143

    CAS  PubMed  Google Scholar 

  8. Blak GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ. Res. 2001;89:763–771

    Google Scholar 

  9. Doweik L, Maca T, Schillinger M, et al. Fibrinogen predicts mortality in high risk patients with peripheral artery disease. Eur. J. Vasc. Endovasc. Surg. 2003;26:381–386

    Article  CAS  PubMed  Google Scholar 

  10. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 1997;26:517–538

    Article  CAS  PubMed  Google Scholar 

  11. Lam TH, Liu LJ, Janus ED, et al. Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of type 2 diabetes mellitus and impaired glucose tolerance. Diabet. Med. 2000;17:798–806

    Article  CAS  PubMed  Google Scholar 

  12. Van Den Biggelaar AH, De Craen AJ, Gussekloo J, et al. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 2004;18:1022–1024

    Google Scholar 

  13. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vasc. Med. 1997;2:115–125

    CAS  PubMed  Google Scholar 

  14. Margaglione M, Grandone E, Mancini FP, et al. Genetic modulation of plasma fibrinogen concentrations: possible importance of interleukin-6. J. Thromb. Thrombolysis 1996;3:51–56

    Article  CAS  PubMed  Google Scholar 

  15. Ernst E. Regular exercise reduces fibrinogen levels: a review of longitudinal studies. Br. J. Sports Med. 1993;27:175–176

    Article  CAS  PubMed  Google Scholar 

  16. Behague I, Poirier O, Nicaud V, et al. Beta-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM study. Circulation 1996;93:440–449

    CAS  PubMed  Google Scholar 

  17. Tracy RP. Epidemiological evidence for inflammation in cardiovascular disease. Thromb. Haemost. 1999;82:826–831

    CAS  PubMed  Google Scholar 

  18. The I.C.A.I. Group. Long-term mortality and its predictors in patients with critical leg ischemia. Eur. J. Vasc. Endovasc. Surg. 1997;14:91–95

    Google Scholar 

  19. O’Malley T, Langhorne P, Elton RA, et al. Platelet size in stroke patients. Stroke 1995;26:995–999

    CAS  PubMed  Google Scholar 

  20. Martin JF, Bark PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:409–411

    Google Scholar 

  21. Turczynski B, Slowinska L, Szczesny S, et al. The whole blood and plasma viscosity changes in course of acute myocardial infarction. Pol. Arch. Med. Wewn. 2002;108:971–978

    PubMed  Google Scholar 

  22. Cheng SWK, Ting ACW, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann. Vasc. Surg. 1997;11:217–223

    Article  CAS  PubMed  Google Scholar 

  23. Anderson JL, Muhlestein JB, Home BD, et al. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive proteins in patients with angiographically defined coronary artery disease. Circulation 2000;102:1227–1232

    CAS  PubMed  Google Scholar 

  24. Eikelboom JW, Lonn E, Genest J Jr, et al. Homocysteine, and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 1991;131:363–375

    Google Scholar 

  25. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur. J. Cardiovasc. Prev. Rehabil. 2004;2:101–112

    Google Scholar 

  26. Germing A, von Dryander S, Machraoui A, et al. Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting. Heart Vessels 2000;6:263–267

    Google Scholar 

  27. Salomaa V, Matei C, Aleksic N, et al. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study: atherosclerosis risk in community. Atherosclerosis 2001;157:309–314

    Article  CAS  PubMed  Google Scholar 

  28. Wada H, Mori Y, Okabayashi K, et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am. J. Hematol. 2003;72:1–7

    Article  PubMed  Google Scholar 

  29. Liu Y, Saha N, Heng CK, et al. Fibrinogen genotypes (α and β) are associated with plasma fibrinogen levels in Chinese. J. Med. Genet. 2001;38:E1

    Article  Google Scholar 

  30. Kobayashi S, Inoue N, Ohashi Y, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler. Thromb. Vasc. Biol. 2003;23:1398–1404

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Pokfulam Road, Hong Kong, China

    Bernice L.Y. Cheuk Ph.D., Grace C.Y. Cheung B.Sc. M.Sc., Silvana S.F. Lau B.Sc. M.Sc. & Stephen W.K. Cheng M.S.

Authors
  1. Bernice L.Y. Cheuk Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grace C.Y. Cheung B.Sc. M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvana S.F. Lau B.Sc. M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen W.K. Cheng M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen W.K. Cheng M.S..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheuk, B.L., Cheung, G.C., Lau, S.S. et al. Plasma Fibrinogen Level: an Independent Risk Factor for Long-term Survival in Chinese Patients with Peripheral Artery Disease?. World J. Surg. 29, 1263–1267 (2005). https://doi.org/10.1007/s00268-005-7802-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7802-4

Keywords

Search

Navigation